Pfizer (PFE) Financials

$28.45

$-0.36 (-1.25%)

As on 04-Sep-2026 16:28EDT

Market cap

$164,208 Mln

Revenue (TTM)

$63,696 Mln

P/E Ratio

37.9

P/B Ratio

1.9

Div. Yield

5.9 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	63,696.00	62,579.00	63,627.00	59,553.00	100,330.00	81,288.00
Cost of Revenue	18,267.00	18,565.00	21,781.00	29,213.00	38,240.00	34,413.00
Gross Profit	45,429.00	44,014.00	41,846.00	30,340.00	62,090.00	46,875.00
Operating Expenses	29,453.00	28,577.00	25,363.00	25,048.00	24,541.00	26,082.00
Operating Profit (EBIT)	15,976.00	15,437.00	16,483.00	5,292.00	37,549.00	20,793.00
Other Income	--	--	--	--	-217.00	4,878.00
Profit before Tax	4,209.00	7,520.00	8,023.00	1,058.00	34,729.00	24,311.00
Provision for Tax	-164.00	-266.00	-28.00	-1,114.00	3,328.00	1,852.00
Profit after Tax (Net Income)	4,335.00	7,770.00	8,020.00	2,133.00	31,365.00	22,147.00
Minority Interest	-35.00	-41.00	-31.00	-39.00	-35.00	-45.00
Consolidated Profit	1,893.00	7,771.00	8,031.00	2,119.00	31,372.00	21,979.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	85,190.00	86,476.00	88,203.00	89,288.00	95,917.00	77,463.00
Minority Interest	-35.00	--	--	274.00	256.00	262.00
Non-Current Liabilities	82,993.00	84,401.00	81,904.00	89,419.00	59,151.00	61,343.00
Current Liabilities	32,646.00	36,984.00	42,995.00	47,794.00	42,138.00	42,671.00
Total Liabilities	233,777.00	208,160.00	213,396.00	226,501.00	197,206.00	181,477.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	159,773.00	165,262.00	163,038.00	183,168.00	145,944.00	121,782.00
Current Assets	41,358.00	42,898.00	50,358.00	43,333.00	51,259.00	59,693.00
Total Assets	233,777.00	208,160.00	213,396.00	226,501.00	197,206.00	181,477.00
Total Debt*	63,194.00	67,416.00	66,993.00	75,041.00	35,829.00	38,436.00
Net Current Assets	8,712.00	5,914.00	7,363.00	-4,461.00	9,121.00	17,022.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	11,705.00	12,744.00	8,700.00	29,267.00	32,580.00
Cash Flow from Investing Activities	--	-1,351.00	2,652.00	-32,278.00	-15,783.00	-22,546.00
Cash from Financing Activities	--	-10,304.00	-17,140.00	26,066.00	-14,834.00	-9,816.00
Net Cash Inflow / Outflow	--	--	--	--	-1,350.00	218.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	0.76	1.37	1.41	0.38	5.46	3.84
Cash EPS ($)	0.76	2.53	2.64	1.49	6.09	4.48
Adjusted Book Value ($)	14.95	15.21	15.47	15.81	16.70	13.43
Dividend per Share ($)	5.93	--	--	--	--	--
Cash Flow per Share ($)	--	2.06	2.23	1.54	5.10	5.65
Free Cash Flow per Share ($)	--	1.60	1.72	0.85	4.53	5.18

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	5.03	5.02	1.44	25.33	20.21
ROE (%)	5.01	8.90	9.04	2.30	36.18	31.43
ROA (%)	1.82	3.69	3.65	1.01	16.57	13.19
EBIT Margin (%)	10.84	16.29	17.47	5.49	35.85	31.50
Net Margin (%)	6.81	12.42	12.60	3.58	31.33	25.70
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	-0.21	-0.02	0.07	-0.41	0.23	0.95
EBIT Growth (%)	-56.79	-8.30	240.19	-90.92	40.49	201.66
Net Profit Growth (%)	-59.86	-3.12	276.00	-93.20	41.62	141.81
EPS Growth (%)	-59.89	-0.03	2.72	-0.93	0.42	1.37
Book Value Growth (%)	-3.83	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	37.91	18.22	18.87	76.22	9.38	15.38
Price / Book Value	1.91	1.64	1.72	1.82	3.07	4.40
Dividend Yield (%)	5.93	--	--	--	--	--
EV/EBITDA	15.88	12.94	10.91	23.54	7.49	11.30
Close Price ($)	24.08	24.90	26.53	28.79	51.24	59.05
High Price ($)	28.75	27.69	31.54	51.60	59.80	61.71
Low Price ($)	23.11	20.92	24.48	25.76	41.45	33.36
Market Cap ($ Cr)	164,207.59	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.71	0.78	0.76	0.84	0.37	0.50
Short term debt to equity ratio	0.03	0.04	0.08	0.12	0.03	0.03
Current Ratio	1.27	1.16	1.17	0.91	1.22	1.40
Quick Ratio	0.96	0.87	0.92	0.69	1.00	1.19
Interest Coverage	2.56	3.82	3.60	1.48	29.05	19.83

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	19.61	25.31	23.22	18.77	14.48	19.37
Asset Turnover	0.27	0.30	0.29	0.28	0.53	0.48
Receivable days	--	89.35	74.49	78.83	55.11	60.52
Inventory Days	--	211.55	176.41	119.84	86.15	90.77
Payable days	--	106.96	103.49	84.51	59.16	52.47
Cash Conversion Cycle	--	193.94	147.42	114.16	82.10	98.83

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)